MARKET

CAPR

CAPR

Capricor Therapeutics Inc
NASDAQ
8.36
-0.21
-2.45%
After Hours: 8.43 +0.07 +0.84% 19:59 09/25 EDT
OPEN
8.61
PREV CLOSE
8.57
HIGH
8.67
LOW
8.30
VOLUME
1.92M
TURNOVER
--
52 WEEK HIGH
40.37
52 WEEK LOW
2.960
MARKET CAP
486.04M
P/E (TTM)
-3.4132
1D
5D
1M
3M
1Y
5Y
1D
CAPR Deadline: CAPR Investors with Losses in Excess of $100K Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit
PR Newswire · 1d ago
CAPR 5-DAY DEADLINE: Capricor Investors Have Opportunity to Lead Class Action - HBSS
Barchart · 3d ago
These beaten-down stocks could bounce back in January, if history is any guide
MarketWatch · 4d ago
Weekly Report: what happened at CAPR last week (0914-0918)?
Weekly Report · 5d ago
FDA, Duke-Margolis workshop to examine evidence standards for rare diseases
Seeking Alpha · 5d ago
10 small-cap U.S. healthcare stocks with the weakest momentum grades
Seeking Alpha · 09/18 14:20
Small-cap stocks with weak momentum grades and steep YTD losses
Seeking Alpha · 09/18 13:55
Biotech Stocks In Focus: Aethlon, Tiziana, Capricor, Firefly & Clearmind
NASDAQ · 09/17 18:28
More
About CAPR
Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program focuses on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate, Deramiocel (also referred to as CAP-1002), is an allogeneic cardiac-derived cell therapy. The clinical development program for Deramiocel has focused primarily on adolescents and young adults with DMD, including many patients who are non-ambulatory and experiencing progressive cardiac and skeletal muscle decline. Its StealthX exosome platform program consists of engineered exosomes for vaccine and therapeutic development. The StealthX vaccine is a proprietary vaccine developed internally utilizing exosomes that were engineered to express either spike or nucleocapsid proteins on the surface.

Webull offers Capricor Therapeutics Inc stock information, including NASDAQ: CAPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAPR stock methods without spending real money on the virtual paper trading platform.